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Aims. To investigate the effect of biliary stent placement without endoscopic sphincterotomy (EST) on common bile duct stones
(CBDS) disappearance and the contribution of preserving the duodenal papilla function to reduce recurrence of CBDS.Methods.
Sixty-six patients admitted for acute obstructive cholangitis due to CBDS who underwent biliary stent placement without EST for
2 years fromMarch 2011 were evaluated retrospectively. The second endoscopic retrograde cholangiopancreatography (ERCP) was
performed for treatment of CBDS 3 to 4 months after the first ERCP. We estimated the rate of stone disappearance at the time
of second ERCP. Results. CBDS disappearance was observed in 32 (48.5%) of 66 patients. The diameter of the bile ducts and the
diameter of CBDS in patients with CBDS disappearance were significantly smaller than in those with CBDS requiring extraction
(𝑝 = 0.007 and 𝑝 < 0.001, resp.). Stone disappearance was evident when the diameter of bile ducts and that of CBDS were <10 and
7mm, respectively (𝑝 = 0.002). Conclusions. Short-term stent placement without EST eliminates CBDS while preserving duodenal
papilla function and may be suitable for treating CBDS in patients with nondilated bile ducts and small CBDS.
1. Introduction
To treat common bile duct stones (CBDS), endoscopic
sphincterotomy (EST) is an established procedure and is
widely performed. However, late complications including
liver abscess, cholangitis, CBDS recurrence, and bile duct
cancer have recently been reported with this technique
[1, 2], the occurrence of which is probably due to reflux
into the bile duct of duodenal juice, which contains both
pancreatic juice and bacteria. It is desirable to avoid such
complications in younger patients, who have a long life
expectancy.
Endoscopic papillary balloon dilation is an alternative
method for treatment of CBDS [3], and it has the advantage of
preserving duodenal papillary function [4]. However, com-
pared with EST, a higher rate of postendoscopic retrograde
cholangiopancreatography (ERCP) pancreatitis (PEP) has
been reported [4], and this remains a potential hazard when
using this method for treatment of CBDS.
Biliary stent placement is widely performed for acute
obstructive cholangitis (AOC) due to CBDS. This procedure
is easy to perform, effective, and accepted as an emergent
treatment [5, 6]. In patients with difficult stones, biliary stent
placement to drain obstructed bile juice due to CBDS can
be selected [7–10]. Some reports have described a decrease
in size and diameter, as well as disappearance of stones in
patients with biliary stent placement after EST [7, 8].
We performed biliary stent placement in patients of
various ages for AOC due to CBDS without EST during
their first hospitalization. These patients were discharged
temporarily after evidence of relief of AOC, and readmission
for extraction of CBDS was scheduled 3 to 4 months after
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Table 1: Patient characteristics (𝑛 = 66).
Characteristics 𝑛
Male/female 43/23
Mean age (years) 68.5 (36–94)
Cholangitis
Grade III/II/I 3/24/39
Gallbladder with/without gallstones 45/14
the first hospitalization. When endoscopic treatments were
initiated at the second hospitalization, stone disappearance
occurred in about half of patients. Herein, we report our
findings in these patients.
2. Subjects and Methods
Sixty-six patients admitted forAOCdue toCBDSwho under-
went biliary stent placement for 2 years fromMarch 2011 were
evaluated retrospectively. Patients with a past history of EST
and biliary tract malignancies such as gallbladder carcinoma
or bile duct carcinoma were excluded. Of the 66 patients,
43 were male and 23 were female. The mean age of these
patients was 68.5 years (range: 36–94 years) (Table 1). Severity
of AOC was confirmed in accordance with the 2013 Tokyo
Guidelines [11]. Severity grades III, II, and I were noted in
3, 24, and 39 patients, respectively. Of the 59 patients with
a gallbladder, 45 had gallbladder stones. This retrospective
study was approved by the institutional review board of
Shizuoka General Hospital.
Diagnosis of CBDS was confirmed by recognition of
a movable filling defect on endoscopic retrograde cholan-
giopancreatography (ERCP), and a 7 Fr/7 cm double-pigtail
stent (Olympus, Japan) was placed in all of these patients.
Biliary stent placement was performed with a lateral-viewing
endoscope (JF 260, Olympus, Japan). Bile duct diameter and
CBDS were measured using ERCP images. After cannulating
a bile duct, a small amount of contrast medium (60%
Urographin, Bayer) was injected and CBDS was identified,
followed by selective cannulation of the relevant bile duct.
Bile juice was aspirated as much as possible, and a cholan-
giogram showing intrahepatic bile ducts and a cystic duct
was recorded. After cholangiography, a 0.035-inch guide wire
(Jagwire, Boston Scientific Japan) was inserted.The 7 Fr/7 cm
double-pigtail biliary stent was placed over the guide-wire
with the objective of fixing the tip of the stent to either hepatic
duct. A pancreatic stent was placed simultaneously in cases
where difficulty placing the cannula selectively extended the
procedure time beyond 10 minutes, misinjection into the
pancreatic duct occurredmore than 3 times, or a small orifice
in the major papilla was present.
Oral food intake was started on the day after stent place-
ment, if symptoms of AOC such as pain, fever, and abnor-
mal laboratory data were relieved. Patients were discharged
temporarily if aggravation of AOC was not recognized after
starting oral food intake. Readmission was scheduled for
endoscopic treatment of CBDS 3 to 4 months after the first
Table 2: Stone disappearance (𝑛 = 66).
Stone disappearance/persistence (𝑛) 32/34
Stone disappearance rate (%) 48.5
hospitalization. In patients with gallstones, cholecystectomy
was performed before the second admission.
With the second ERCP, identification of CBDS was
achieved by cholangiography while maintaining a biliary
stent in the bile duct. When a filling defect revealing CBDS
was absent, the biliary stent was removed and treatment for
CBDS was terminated. On the other hand, when a filling
defect showing CBDS was recognized, extraction of CBDS
using a basket catheter was performed after removing the bil-
iary stent with EST, or without EST because of small diameter
of the stone. In patients treated with an anticoagulant, the
biliary stent was maintained in place.
We estimated the rate of stone disappearance and com-
pared diameters of bile ducts, diameters of CBDS, number
of CBDS, ratio of calcified CBDS to total CBDS, and dura-
tion from discharge to second admission in the 2 groups
(i.e., those with stone disappearance and stone persistence).
Stone disappearance was confirmed by ERCP. Complications
associated with endoscopic procedures were evaluated. The
recurrence rate of CBDS after the second ERCP with an
average follow-up period of 34.3 months (9–44 months) was
estimated, while recurrence of CBDS was evaluated with
recurrence of symptoms of cholangitis.
The data obtained in this study were statistically analyzed
by Student’s 𝑡-test and Fisher’s exact test to determine factors
related to stone disappearance. 𝑝 values <0.05 were regarded
as statistically significant.
3. Results
CBDS disappeared in 32 (48.5%) of 66 patients (Table 2).
Diameters of the bile ducts and the diameter of CBDS in
patients with stone disappearance (Table 3) were significantly
smaller than in those without stone disappearance (𝑝 = 0.007
and 𝑝 < 0.001, resp.). The number of stones, ratio of calcified
stones, and duration from first hospitalization discharge to
second admission were not significantly different between
the 2 groups (𝑝 = 0.998, 𝑝 = 0.180, and 𝑝 = 0.205,
resp.). Seventeen patients had bile duct and CBDS diameters
of <10 and 7mm, respectively (Table 4). CBDS disappeared
in 14 (82.4%) of the 17 patients. When the diameters of the
bile duct and stones were <10 and 7mm, respectively, CBDS
disappeared readily (𝑝 = 0.002).
With respect to complications (Table 5), mild post-ERCP
pancreatitis and middle hepatic vein thrombosis were expe-
rienced in 4 (6.1%) patients and 1 (1.5%) patient, respectively.
The latter complication was caused by compression of the
middle hepatic vein by the tip of the stent placed at the caudal
lobe.
During the second ERCP (Table 6), 32 patients with
stone disappearance underwent biliary stent removal and
the treatment for CBDS was completed. Among patients
without stone disappearance, stone extraction using a basket
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Table 3: Analysis of factors associated with stone disappearance and persistence (𝑛 = 66).
CBDS disappearance (𝑛 = 32) CBDS persistence (𝑛 = 34) 𝑝 value
Diameter of bile ducts (mm) 9.59 ± 3.43 12.20 ± 4.17 0.007
Diameter of bile duct stones (mm) 5.77 ± 3.01 11.21 ± 6.42 <0.001
Number of bile duct stones (pieces) 1.56 ± 0.98 1.55 ± 1.02 0.988
Ratio of calcified stones (%) 75.8 91.1 0.180
Duration from first hospitalization discharge to second
admission (days) 143 ± 10 111 ± 58 0.205
Table 4: Stone disappearance in patients with CBD < 10mm and CBDS < 7mm.
Diameter
𝑝 value
CBD < 10mm and CBDS < 7mm CBD ≥ 10mm or CBDS ≥ 7mm
CBDS disappearance 14/17 (82.4%) 18/49 (36.7%) 0.002
Table 5: Complications.
Complications 𝑛 (%)
Mild pancreatitis 4 (6.1)
Hepatic vein thrombosis 1 (1.5)
catheter with EST was performed in 17 (25.8%) patients
and stone extraction using a basket catheter without EST
because of small stone diameter and a widely opened papilla
orifice due to stent placement (phenomenon which was
frequently experienced in our study) was performed in 10
(15.1%) patients. Biliary stent replacement, for persistent
biliary stent placement due to a large stone, and anticoagulant
administration were performed in 7 (10.6%) patients. Finally,
CBDS were treated without disruption of duodenal papilla
function in 42 (63.6%) patients (Figure 1).
During an average follow-up period of 34.3 months
(Table 6), cholangitis due to stone recurrence was experi-
enced in 1 (3.1%) patient with stone disappearance, 2 (11.8%)
patients with EST, and 1 (10%) patient with stone extraction
without EST. However, the recurrence rate of cholangitis
was not significantly different between the two groups:
stone disappearance or stone extraction by a basket catheter
without EST and stone extraction with EST (𝑝 = 0.57).
4. Discussion
Several studies have investigated stent placement for the
treatment of CBDS in cases with stones that cannot be
removed by ordinary endoscopic treatments including EST
[7–10]. In one report, plastic stent placement was evaluated
for the treatment of large CBDS in 45 patients [7]. Among
all 45 patients, EST was performed in cases where extrac-
tion of CBDS failed. A decrease in the size of stones was
observed in almost all patients and CBDS disappearance
occurred in 22.2% of patients. Agitation of CBDS within
the bile duct where the stent was located was suggested to
be the most likely explanation for these results. In another
report [8], placement of a pigtail stent after EST resulted
in disappearance in 7 (35%) of 20 patients and a decrease
in the size of CBDS in 11 (55%) of 20 patients, presum-
ably caused by grinding of the placed stent against the
stone.
Stent placement for 2 months was reported to contribute
to a decrease in the number and size of CBDS in almost
all of a cohort of 40 patients who did not undergo EST [9].
CBDS diameters were greater than 20mm in many patients;
moreover, disappearance of small CBDS was observed. The
authors presumed that disruption of stones caused by the
placed stent contributed to a decrease in CBDS diameters
and numbers. Friability of stones was also described as
a possible mechanism over the short term, resulting in
facilitation of endoscopic procedures using a lithotriptor for
CBDS [12]. Agitation, grinding, and friability of stones might
contribute to the destruction of CBDS, enabling them to
be discharged, and preserving duodenal papilla function in
patients who have not undergone EST is also considered to be
responsible for disappearance of small CBDS by facilitating
their discharge. In another report, discharge of CBDS with
preservation of the duodenal papilla was observed during
ERCP [13]. This suggests that discharge of CBDS is a possible
mechanism for CBDS disappearance.
In our study, CBDS disappeared with short-term stent
placement for about 3 months without EST in about 50%
of patients. Smaller sizes of CBD and CBDS were associated
with CBDS disappearance. Short-term stent placement could
contribute to CBDS disappearance, especially in patients
with CBD diameters of <10mm and CBDS diameters of
<7mm. The most likely mechanism of the disappearance
in our cases was discharge of CBDS through the functional
duodenal papilla, in addition to agitation caused by the placed
stent. This is because the smaller CBDS would be discharged
more readily through the duodenal papilla and the smaller
bile duct could be associated with preserved bile excretion
function of the duodenal papilla and probably with CBDS
discharge.
Previous studies differ from ours in that the endoscopic
treatments used for patients in those studies, including EST,
were not successful in removing the stones. In our patients,
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Table 6: Procedures during the second ERCP and cholangitis after the second ERCP.
Procedures during the second ERCP 𝑛 (%) Cholangitis
𝑛 (%)
Stone disappearance Biliary stent removal 32 (48.5) 1 (3.1)#
Stone persistence
Stone extraction with EST 17 (25.8) 2 (11.8)#
Stone extraction by a basket catheter without EST 10 (15.1) 1 (10)#
Biliary stent replacement for persistent biliary stent placement 7 (10.6) 3 (42.9)
#𝑝 = 0.57.
# shows statistical significance between “Biliary stent removal” plus “Stone extraction by a basket catheter without EST”, and “Stone extraction with EST”.
CBDS treated without disruption of duodenal papilla function (n = 42, 63.6%)
Biliary stent replacement for persistent biliary stent placement (n = 7, 10.6%)
Stone extraction by a basket catheter without EST (n = 10, 15.1%)
Stone extraction with EST (n = 17, 25.8%)
Stone persistence (n = 34, 51.5%)
Biliary stent removal (n = 32, 48.5%)
Stone disappearance (n = 32, 48.5%)
Biliary stent for cholangitis due to CBDS (n = 66)
Figure 1: Flow diagram of patients analyzed in this study.
we did not attempt to remove CBDS by EST before stent
placement, and we did not always encounter stones that were
difficult to treat. These factors could have contributed to the
higher rate of stone disappearance in our study compared
with previous reports.
Although EST is widely performed to treat CBDS, com-
plications including perforation, hemorrhage, and pancre-
atitis are experienced during or after the procedure [14,
15]. Moreover, disruption of the duodenal papilla lets the
duodenal juice, including pancreatic juice and bacteria, reflux
into the bile duct, which can induce liver abscess, cholangitis,
and CBDS recurrence as late complications [1, 2]. Our results
showed that recurrent cholangitis during an average follow-
up period of 34.3 months occurred in 11.8% of patients with
EST as the second ERCP procedure, while, compared with a
group of patients who did not undergo EST because of stone
disappearance or stone extraction without EST following
biliary stent placement, the recurrence rate of cholangitis was
not significantly different. However, the follow-up period was
too short to estimate complications correctly.
Our method compelled patients to be admitted twice.
In spite of the fact, the advantage of our method is the
preservation of duodenal papilla function. Moreover, if the
size of bile duct and CBDS is <10 and 7mm, respectively,
the disappearance rate is high and statistically significant.
Patients that meet these criteria have the potential to experi-
ence great benefit with the procedure. In particular, younger
patients with bile duct size and CBDS <10 and 7mm,
respectively, may be ideal candidates, because they have a
long life expectancy and avoiding destruction of the duodenal
papilla function would therefore be highly desirable.
We propose the following new strategy for CBDS treat-
ment. For younger patients with CBD diameters of <10mm
and CBDS diameters of <7mm, a biliary stent is placed
temporarily for 3 months and a second ERCP is performed.
If the CBDS disappears, the treatment is considered complete
and the stent is removed. Patients with relatively large
persistent stones would be indicated to undergo EST with
stone extraction. In those with small but persistent stones,
EST would not be needed for stone extraction.
We deemed that stones had disappeared by confirming
the absence of a filling defect on ERCP. This is a typical
method used to judge stone disappearance. Persistent stones
cannot be excluded completely by ERCP if they are small
in diameter. However, our results showed that even if small
stones remained that could not be confirmed on ERCP, they
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would not be of clinical importance, because no cases of
cholangitis occurred after the second ERCP in patients whose
stones were judged to have disappeared.
5. Conclusions
Our study suggests that short-term stent placement without
EST is effective for the treatment of CBDS with preservation
of duodenal papilla function. Suitable initial candidates for
this method of treatment are patients with nondilated bile
ducts and small CBDS. Further study is warranted to confirm
our results, because this study was limited by a small sample
size and was performed at a single center.
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